Drysdalin, an antagonist of nicotinic acetylcholine receptors highlights the importance of functional rather than structural conservation of amino acid residues.
Cys‐loop receptor recognition
nicotinic acetylcholine receptor
nonhomologous mutation
protein‐protein interaction
snake venom neurotoxin
Journal
FASEB bioAdvances
ISSN: 2573-9832
Titre abrégé: FASEB Bioadv
Pays: United States
ID NLM: 101733210
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
30
07
2018
revised:
30
07
2018
accepted:
19
10
2018
entrez:
4
3
2020
pubmed:
10
1
2019
medline:
10
1
2019
Statut:
epublish
Résumé
Snake venom neurotoxins are potent antagonists of nicotinic acetylcholine receptors (nAChRs). Here, we describe a novel member of class 3c long-chain neurotoxin drysdalin from the venom of
Identifiants
pubmed: 32123825
doi: 10.1096/fba.1027
pii: FBA21027
pmc: PMC6996315
doi:
Types de publication
Journal Article
Langues
eng
Pagination
115-131Informations de copyright
© 2018 The Authors.
Déclaration de conflit d'intérêts
5The authors declare that they have no conflict of interest.
Références
ACS Chem Biol. 2015 Dec 18;10(12):2805-15
pubmed: 26448325
Pharmacol Ther. 2013 Jan;137(1):22-54
pubmed: 22925690
Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):678-80
pubmed: 6402200
Physiol Rev. 2009 Jan;89(1):73-120
pubmed: 19126755
Toxicon. 2013 May;66:47-58
pubmed: 23416229
Biochem J. 2013 Sep 1;454(2):311-21
pubmed: 23802200
Cell Mol Neurobiol. 2005 Jun;25(3-4):513-52
pubmed: 16075378
J Biol Chem. 1999 Dec 3;274(49):34851-8
pubmed: 10574958
BMC Biotechnol. 2008 Dec 04;8:91
pubmed: 19055817
Biochemistry. 1999 Jun 15;38(24):7847-55
pubmed: 10387025
FEBS J. 2007 Aug;274(15):3799-845
pubmed: 17651090
J Chem Biol. 2010 Mar;3(1):37-44
pubmed: 19779939
Pharmacol Rev. 2009 Mar;61(1):39-61
pubmed: 19293145
Biochem Pharmacol. 2011 Jan 15;81(2):314-25
pubmed: 20950587
AAPS J. 2006 Jan 13;7(4):E885-94
pubmed: 16594641
Mar Drugs. 2017 Jun 09;15(6):
pubmed: 28598389
Toxicon. 2001 Sep;39(9):1353-7
pubmed: 11384723
EMBO J. 2005 Apr 20;24(8):1512-22
pubmed: 15791209
J Med Chem. 2005 Jul 28;48(15):4705-45
pubmed: 16033252
Trends Pharmacol Sci. 2015 Feb;36(2):109-23
pubmed: 25528970
J Nutr. 2007 Jun;137(6 Suppl 1):1504S-1508S; discussion 1516S-1517S
pubmed: 17513416
J Biol Chem. 2002 Oct 4;277(40):37439-45
pubmed: 12133834
Biochem J. 2013 Sep 1;454(2):303-310
pubmed: 23800261
Pharmacol Ther. 1987;34(3):403-51
pubmed: 3324114
J Biol Chem. 2010 Mar 12;285(11):8302-15
pubmed: 20071329
J Biol Chem. 2000 Sep 22;275(38):29594-601
pubmed: 10852927
Br J Pharmacol Chemother. 1960 Sep;15:410-1
pubmed: 13705512
Clin Exp Pharmacol Physiol. 2002 Sep;29(9):815-22
pubmed: 12165048
J Biol Chem. 1995 Apr 21;270(16):9362-9
pubmed: 7721859
Pharmacol Rev. 2011 Dec;63(4):938-66
pubmed: 21969327
Biochem Pharmacol. 2012 Sep 15;84(6):851-63
pubmed: 22771828
Biochemistry. 1985 Mar 12;24(6):1532-7
pubmed: 3986193
Nat Neurosci. 2007 Aug;10(8):953-62
pubmed: 17643119
J Proteome Res. 2011 Feb 4;10(2):739-50
pubmed: 21133350